| 1 |
28737446 | Quantitative in vitro phenotyping and prediction of drug interaction potential of CYP2B6 substrates as victims. | 2018 Jul |
1 |
| 2 |
27386066 | "Influence of methadone on clopidogrel in addicts on methadone maintenance therapy" Drug interaction between methadone and clopidogrel. | 2016 Spring |
1 |
| 3 |
24855828 | Identification of CYP2C19 inhibitors from phytochemicals using the recombinant human enzyme model. | 2014 May |
1 |
| 4 |
23474500 | Comparative xenobiotic metabolism capacities and pesticide sensitivity in adults of Solea solea and Solea senegalensis. | 2013 May |
1 |
| 5 |
22652334 | Assessment of drug-drug interactions caused by metabolism-dependent cytochrome P450 inhibition. | 2012 Jun 25 |
2 |
| 6 |
21148250 | Simple, direct, and informative method for the assessment of CYP2C19 enzyme inactivation kinetics. | 2011 Mar |
1 |
| 7 |
21178986 | Differential impacts of CYP2C19 gene polymorphisms on the antiplatelet effects of clopidogrel and ticlopidine. | 2011 Feb |
2 |
| 8 |
19948947 | Metabolism and disposition of the thienopyridine antiplatelet drugs ticlopidine, clopidogrel, and prasugrel in humans. | 2010 Feb |
1 |
| 9 |
19144769 | Differential time- and NADPH-dependent inhibition of CYP2C19 by enantiomers of fluoxetine. | 2009 Apr |
1 |
| 10 |
19845434 | Comparison of mechanism-based inhibition of human cytochrome P450 2C19 by ticlopidine, clopidogrel, and prasugrel. | 2009 Nov |
4 |
| 11 |
18474675 | Cytochrome P450 2B6 catalyzes the formation of pharmacologically active sibutramine (N-{1-[1-(4-chlorophenyl)cyclobutyl]-3-methylbutyl}-N,N-dimethylamine) metabolites in human liver microsomes. | 2008 Aug |
1 |
| 12 |
19122335 | Comparison of human cytochrome P450 inhibition by the thienopyridines prasugrel, clopidogrel, and ticlopidine. | 2008 |
1 |
| 13 |
17307149 | 3D structure modeling of cytochrome P450 2C19 and its implication for personalized drug design. | 2007 Apr 6 |
1 |
| 14 |
17332142 | Evaluation of 3-O-methylfluorescein as a selective fluorometric substrate for CYP2C19 in human liver microsomes. | 2007 Jun |
1 |
| 15 |
16272957 | Interaction magnitude, pharmacokinetics and pharmacodynamics of ticlopidine in relation to CYP2C19 genotypic status. | 2005 Dec |
4 |
| 16 |
14563790 | Potent mechanism-based inhibition of human CYP2B6 by clopidogrel and ticlopidine. | 2004 Jan |
1 |
| 17 |
14977868 | In vitro sulfoxidation of thioether compounds by human cytochrome P450 and flavin-containing monooxygenase isoforms with particular reference to the CYP2C subfamily. | 2004 Mar |
2 |
| 18 |
15056479 | The metabolism of the piperazine-type phenothiazine neuroleptic perazine by the human cytochrome P-450 isoenzymes. | 2004 May |
1 |
| 19 |
15155554 | Selective inhibition of CYP2B6-catalyzed bupropion hydroxylation in human liver microsomes in vitro. | 2004 Jun |
1 |
| 20 |
12721102 | Contribution of human cytochrome p-450 isoforms to the metabolism of the simplest phenothiazine neuroleptic promazine. | 2003 Apr |
1 |
| 21 |
11181505 | Metabolic characterization of the major human small intestinal cytochrome p450s. | 2001 Mar |
2 |
| 22 |
11580286 | Ticlopidine as a selective mechanism-based inhibitor of human cytochrome P450 2C19. | 2001 Oct 9 |
17 |
| 23 |
11764927 | Inhibition by ticlopidine and its derivatives of human liver cytochrome p450. Mechanism-based inactivation of CYP 2C19 by ticlopidine. | 2001 |
1 |
| 24 |
10759690 | In vitro inhibition of the cytochrome P450 (CYP450) system by the antiplatelet drug ticlopidine: potent effect on CYP2C19 and CYP2D6. | 2000 Apr |
3 |
| 25 |
10233213 | Ticlopidine decreases the in vivo activity of CYP2C19 as measured by omeprazole metabolism. | 1999 Apr |
6 |
| 26 |
10460802 | The role of CYP2C19 in the metabolism of (+/-) bufuralol, the prototypic substrate of CYP2D6. | 1999 Sep |
1 |
| 27 |
10497136 | Heterologous expression and kinetic characterization of human cytochromes P-450: validation of a pharmaceutical tool for drug metabolism research. | 1999 Oct |
1 |
| 28 |
10613611 | Ticlopidine inhibits phenytoin clearance. | 1999 Dec |
1 |
| 29 |
9390115 | Ticlopidine inhibition of phenytoin metabolism mediated by potent inhibition of CYP2C19. | 1997 Nov |
3 |